MicruX is an innovative technology-based company focused on the design, development and manufacture of novel miniaturized analytical systems based on lab-on-a-chip technologies for research and educational activities in microfluidic and electrochemistry f
Dr Luke Parkinson has developed novel tube interconnect port architectures that simplify and greatly improve the connection of microfluidic chip ports to external fluid-carrying tubes.
ALine Inc provides custom design fabrication and prototyping as well as custom microfluidic flow cells for spectrophotometers, fluorometers, MEMs, MOMEMs, custom fabrication and volume manufacture
To develop and deliver microfluidic dispense solutions for our customers in Biomedical, Chemical Sensing, Optical and Electronics industries based on Engineering Arts ActivePipette technology. At the core of our systems is the ActivePipette product whic
Wainamics Inc. is a consulting firm specializing in microfluidic consumable product development for point of care diagnostics and life sciences applications
Fluidigm’s technology supports genomics-based applications such as single-cell gene expression, high sample throughput SNP genotyping and ground-breaking capabilities such as digital PCR and automated target enrichment for next-generation sequencing.
Fluidigm’s technology supports genomics-based applications such as single-cell gene expression, high sample throughput SNP genotyping and ground-breaking capabilities such as digital PCR and automated target enrichment for next-generation sequencing.
Fluidigm’s technology supports genomics-based applications such as single-cell gene expression, high sample throughput SNP genotyping and ground-breaking capabilities such as digital PCR and automated target enrichment for next-generation sequencing.
Fluidigm’s technology supports genomics-based applications such as single-cell gene expression, high sample throughput SNP genotyping and ground-breaking capabilities such as digital PCR and automated target enrichment for next-generation sequencing.
Fluidigm’s technology supports genomics-based applications such as single-cell gene expression, high sample throughput SNP genotyping and ground-breaking capabilities such as digital PCR and automated target enrichment for next-generation sequencing.
Fluidigm’s technology supports genomics-based applications such as single-cell gene expression, high sample throughput SNP genotyping and ground-breaking capabilities such as digital PCR and automated target enrichment for next-generation sequencing.
Fluidigm’s technology supports genomics-based applications such as single-cell gene expression, high sample throughput SNP genotyping and ground-breaking capabilities such as digital PCR and automated target enrichment for next-generation sequencing.
Fluidigm’s technology supports genomics-based applications such as single-cell gene expression, high sample throughput SNP genotyping and ground-breaking capabilities such as digital PCR and automated target enrichment for next-generation sequencing.